3rd Quarter - Report
WINNING STRATEGIES WASHINGTON for KALEO
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reducing opioid overdose deaths; implementation of HR 3680/S. 2256 provisions related to naloxone included in the conference report on S. 524, the Comprehensive Addiction and Recovery Act S.771 Improving Access to Affordable Prescription Drugs Act, S.469 Affordable and Safe Prescription Drug Importation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARL CHIDLOW | — |
| MOLLY MCDONNELL | LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| CHARLA PENN | — |
| CHELSEY PENROD HICKMAN | — |
| ROBERT ZUCKER | — |
Pharmacy PHA
Pharmaceutical drug development including epinephrine for anaphylaxis
| Lobbyist | Covered position, as disclosed |
|---|---|
| CARL CHIDLOW | — |
| MOLLY MCDONNELL | LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance |
| MICHAEL A MEROLA | — |
| DONNA MULLINS | — |
| CHARLA PENN | — |
| CHELSEY PENROD HICKMAN | — |
| ROBERT ZUCKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.